Used in the synthesis of pharmaceutical intermediates for cardiovascular drugs, particularly as a chiral building block in the development of beta-blockers. Its structural features enable high selectivity in receptor binding, improving drug efficacy and reducing side effects. Commonly employed in asymmetric synthesis due to the stable oxazolidinone ring, which acts as a directing group in stereoselective reactions. Also utilized in research settings for developing novel analogs with improved metabolic stability and bioavailability.